OakChart

Flyte Aviation Inc

VJETIndustrials·Airports & Air Services·USA·Nano·AMEX·Nov 12 • 3:41 PM ET

0.53-0.02 (-2.75%)
2026-11-12 21:44 CET
Market cap
$1.12M
Revenue, TTM
1.92 USD m
Net income, TTM
-13.62 USD m
Free cash flow, TTM
-9.35 USD m
EPS diluted, TTM
-73.38
Price / earnings
-
Compare

Price

VJET against its 20, 50 and 200-day averages
Terms2050200Earnings
Patternshover a marker to name it
Sales mean, own scale
RS 0Sales 0.30Price0.300.005.0010.0015.0020.009.6M19.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VJETclose 0.5320-day 0.6450-day 1.13200-day 7.430.53

98.3% under the 52-week high of 30.60 on 10 Dec 2025. 52-week low 0.50 on 6 Nov 2026. Last 15 sessions, 45.0% high to low. This session is unfinished.

Volume 0.11× normal · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50% — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 0 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); Current Ratio: Over 1 — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200

Profile

VJET
52-week range, 0% of the way up
0.5030.60

Flyte Aviation, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins on September 4, 2002 and is headquartered in Fort Mill, SC.

Employees17
IPOSep 27, 2018
Beta-1.02
ATR, 14d0.10
Rel volume0.11
Short float16.75%
Insider own75.65%
Inst own7.02%

Snapshot

6 groups

Valuation

Index-
Market Cap$1.12M
Enterprise Value13.33M
Income-13.62M
Sales1.92M
Book / share48.65
Cash / share0.87
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees17
IPOSep 27, 2018

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales0.58
Price / book0.01
Price / cash0.61
Price / free cash flow-
Value / cash profit-
Value / sales6.94
Quick Ratio0.18
Current Ratio0.19
Debt / equity0.82
Long-term debt / equity0.30
Options and shortNo / Yes

Earnings

Earnings / share-73.38
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth85.23% 84.88%
Past sales growth288.20% 25.89%
Earnings vs last year90.58%
Sales vs last year219.17%
Earnings vs last quarter87.32%
Sales vs last quarter380.66%
Earnings-
Surprise8.64% -4.00%

Ownership

Insiders own75.65%
Insider trades0.00%
Institutions own7.02%
Institution trades4.96%
Return on assets-41.66%
Return on equity-106.82%
Return on capital-57.05%
Gross Margin-68.83%
Operating margin-629.77%
Profit Margin-711.49%
20-day average-17.03%
50-day average-53.03%
200-day average-92.86%

Technical

Shares out2.10M
Shares floating0.51M
Short / float16.75%
Short ratio0.16
Short interest0.09M
52-week high30.60 -98.3%
52-week low0.50 +6.2%
Volatility12.82% 12.45%
Average range0.10
Strength index29.39
Market sensitivity-1.02
Relative volume0.11
Avg Volume540.05K
Volume55,663

Performance

Perf Week-6.71%
Perf Month-39.61%
Perf Quarter-81.04%
Perf Half Y-93.12%
Perf YTD-97.10%
Perf Year-97.70%
Perf 3Y-99.94%
Perf 5Y-100.00%
Perf 10Y-
Recommendation1.00
Target Price380.00
Prev Close0.55
Price0.53
Change %-2.78%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Aug 13, 2019DowngradePiper JaffrayOverweight → Neutral$9 → $1.50+182.6%
Nov 02, 2018InitiatedMaxim GroupBuy$23+4,233.1%

Peers

Mkt cap
TickerCompanyMkt cap
UPWheels Up Experience Inc87.51M
SOARSOAR AI Inc10.25M
FLYXflyExclusive Inc102.59M
JOBYJoby Aviation Inc5.42B
SRFMSurf Air Mobility Inc79.43M
ACHRArcher Aviation Inc3.39B
EVTLVertical Aerospace Ltd64.52M
HOVRNew Horizon Aircraft Ltd84.58M
SKYHSky Harbour Group Corp906.90M
SKYWSkywest Inc3.14B

News

latest 14 of 200
  • Flyte Aviation Launches Flyte Club to Disrupt Jet Cards and Fractional Ownership Programs with Transparent Per-Trip Pricing and Savings Up to 30% (PR Newswire)
  • Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets (PR Newswire)
  • Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population (GlobeNewswire)
  • Flyte Aviation Expands International Operations to Canada (GlobeNewswire) -9.02%
  • Flyte Aviation, One of the Nation's Largest Vision Jet Operators, Congratulates Cirrus Aircraft on Ten Years of Innovation (GlobeNewswire) -8.83%
  • Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott's Perclose Internal Vascular Closure Device (GlobeNewswire)
  • Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner Portal (GlobeNewswire) -8.47%
  • Flyte Aviation Partners with The Philadelphia 76ers (PR Newswire) -17.08%
  • Flyte Aviation Launches Under NYSE American Ticker "VJET" (GlobeNewswire) +7.28%
  • Volato AI Launches with Flyte as First Enterprise Customer (Business Wire)
  • Aviation Stocks Lift Off: Flyte (VTAK) Teams Up with Blade Urban Air Mobility (Newsfile) -21.04%
  • Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus (Business Wire)
  • Catheter Precisions LockeT suture retention device features at ISLAA 2026 (TipRanks)
  • Catheter Precision Divests Non-Core Assets As It Shifts Focus (Benzinga) -6.47%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-18--209-13.8740.431.601
2025Q42026-03-31--209-33.2270.241.701
2025Q32025-11-14--266-17.0460.231.201
2024Q42025-11-13--380-256.02-0.301
2025Q22025-08-11--342-72.7890.210.601
2025Q12025-05-19--380-68.1090.140.301
2024Q32024-11-13-381.9-418-0.100.101
2024Q22024-08-19-1,058--1,0590.09--
2024Q12024-05-06-684-798-684.130.080.201
2023Q42024-04-01-247--180.90.10--
2023Q32023-12-22---537.950.13--
2023Q22023-08-14-570-570-558.20.200.201
2023Q12023-06-08-25,764-646-46,8300.090.071
2022Q42023-04-04-7,049--7,1740.00--
2022Q32022-11-14-8,284-15,200-8,2870.000.001
2022Q22022-08-15-24,700-15,200-24,9540.010.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-7,932,500-5,355,972-5,770,7046.266.95
2019FY-10,283,750-9,690,000-10,290,0447.207.86
2020FY-2,015,900-2,897,500-2,015,4654.414.75
2021FY-512,050-362,425-536,4170.022.45
2022FY-49,362-68,400-49,3650.000.00
2023FY-24,681--24,6780.44-
2024FY--1,691-1,269-0.60
2025FY-159--83.5000.82-
2026FY--608--10.20

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2025-02-181000.300.300.30
2024Q4S2025-02-171000.300.300.30
2024Q4S2025-02-161000.300.300.30
2024Q4S2025-02-151000.300.300.30
2024Q4S2025-02-141000.300.300.30
2024Q4S2025-02-131000.300.300.30
2024Q4S2025-02-121000.300.300.30
2024Q4S2025-02-111000.300.300.30
2024Q4S2025-02-101000.300.300.30
2024Q4S2025-02-091000.300.300.30
2024Q4S2025-02-081000.300.300.30
2024Q4S2025-02-071000.300.300.30
2024Q4S2025-02-061000.300.300.30
2024Q4S2025-02-051000.300.300.30

Estimate history

EPS, annual-3325000.005-5770703.758-10290043.764-2015464.917-536416.555-49365.078-24677.903-1269.215-159.011-73.3794
Period201720182019202020212022202320242025TTM
EPS, quarterly-1058.699-381.678-256.019-68.109-72.789-17.046-33.227-13.874-9.232
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual5.876.2577.1990.2590.0220.0140.4420.420.8191.92
Period201720182019202020212022202320242025TTM
Sales, quarterly0.0930.0960.1490.1430.2120.2260.2380.4321.019
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual000000.0010.0040.0420.1740.361
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.0040.0180.0420.0490.0990.1650.1740.2690.361
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1.920.820.420.440.010.020.267.206.26
Cost of Goods Sold Incl. D&A3.232.182.152.100.581.562.178.854.21
Gross Profit-1.32-1.36-1.73-1.66-0.57-1.54-1.91-1.652.05
Selling, General and Administrative Excl. Other10.7410.829.5115.5222.2227.7333.4956.0833.21
Research and Development0.900.860.270.476.3912.258.964.532.78
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-12.06-12.18-11.24-17.18-22.79-29.27-35.40-57.73-31.16
Interest Expense0.490.280.09-0.000.010.010.250.01
Unusual Expense0.666.512.2453.734.17-2.020.00--
Net Income Before Taxes-13.81-19.50-13.50-70.57-26.86-27.26-35.31-56.94-30.82
Income Taxes-0.62-1.813.140.000.000.000.010.010.01
Consolidated Net Income-13.19-17.70-16.64-70.57-26.86-27.26-35.32-56.96-30.83
Net Income From Continuing Operations-13.01-17.18-16.64-70.57-26.86-27.26-35.32-56.96-30.83
Net Income-13.62-17.18-21.80-71.37-26.86-28.54-36.05-56.96-30.83
EPS (Recurring)-47.57-116.83-1,177.97-11,674.32-43,998.78-563,029.54-2,015,465.04-10,290,036.78-5,770,713.70
EPS (Basic, Before Extraordinaries)-73.38-159.01-1,269.22-24,677.90-49,365.08-536,416.55-2,015,464.92-10,290,043.76-5,770,703.76
EPS (Diluted)-73.38-159.01-1,269.22-24,677.90-49,365.08-536,416.55-2,015,464.92-10,290,043.76-5,770,703.76
EBITDA-9.83-10.07-9.13-15.11-22.37-27.87-33.40-55.98-30.54
Non-Operating Income (Expense)-0.60-0.530.070.340.10-0.000.101.040.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.380.270.041.220.331.502.6916.0110.97
Price To Sales Ratio1.232.413.505.03435.02358.4548.742.0616.12
Gross Margin-68.83-165.93-412.14-376.24-4,057.14-6,990.91-738.61-22.9332.78
Operating Margin-629.77-1,487.30-2,676.90-3,888.01-162,778.57-133,027.27-13,668.34-801.92-498.00
Net Margin-711.49-2,098.05-5,190.71-16,147.51-191,892.86-129,740.91-13,916.99-791.18-492.76
Shares Outstanding0.360.170.040.000.000.000.000.000.00
Market Capitalization1.151.153.612.838.3810.9423.6915.56100.88

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue1.020.430.240.230.210.140.150.10
Cost of Goods Sold Incl. D&A1.600.540.550.550.540.540.540.53
Gross Profit-0.58-0.11-0.31-0.32-0.33-0.40-0.39-0.43
Selling, General and Administrative Excl. Other3.382.112.562.702.513.062.662.43
Research and Development0.140.150.330.280.150.100.090.06
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.96-2.22-2.87-3.02-2.84-3.46-3.05-2.86
Interest Expense0.200.120.080.080.070.050.050.03
Unusual Expense-0.59-0.472.56-0.833.501.28-0.581.23
Net Income Before Taxes-3.62-1.86-6.06-2.27-6.41-4.77-2.49-4.12
Income Taxes-0.31-0.17-0.210.08-0.95-0.723.140.00
Consolidated Net Income-3.31-1.69-5.85-2.34-5.46-4.04-5.63-4.12
Net Income From Continuing Operations-3.29-1.68-5.78-2.25-5.11-4.04-5.63-4.12
Net Income-2.56-3.04-5.78-2.25-5.11-4.04-10.79-4.12
EPS (Recurring)-10.73-15.39-22.93-21.46-37.83-53.00-265.72-301.72
EPS (Basic, Before Extraordinaries)-9.23-13.87-33.23-17.05-72.79-68.11-256.02-381.68
EPS (Diluted)-9.23-13.87-33.23-17.05-72.79-68.11-256.02-381.68
EBITDA-3.28-1.72-2.34-2.49-2.31-2.92-2.52-2.34
Non-Operating Income (Expense)-0.05-0.00-0.560.010.000.020.030.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.210.050.060.060.080.070.010.02
Price To Sales Ratio1.232.003.894.565.388.078.602.03
Gross Margin-56.62-25.93-129.83-141.59-156.13-279.02-263.76-451.04
Operating Margin-388.13-513.43-1,204.20-1,336.73-1,338.68-2,416.78-2,047.65-2,978.12
Net Margin-250.74-703.94-2,427.73-996.02-2,409.91-2,828.67-7,238.93-4,291.67
Shares Outstanding0.360.270.170.160.100.050.040.02
Market Capitalization1.152.723.184.154.563.193.611.36

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments0.092.873.5615.8615.0423.9130.5864.318.24
Short Term Receivables0.150.070.140.000.020.020.791.320.52
Inventories0.090.030.040.000.990.882.782.101.20
Other Current Assets0.060.320.410.981.042.811.861.500.09
Total Current Assets0.393.294.1616.8417.0927.6236.0069.2310.04
Net Property, Plant & Equipment0.230.200.250.003.925.017.884.761.16
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets15.2424.2726.320.000.000.000.000.000.00
Deferred Tax Assets16.25--------
Other Assets0.010.010.010.000.040.810.200.040.07
Total Assets32.1127.7730.7416.8421.0433.4444.0874.0311.27
Short Term Debt Incl. Current Port. of LT Debt0.720.310.280.000.281.040.610.290.04
Accounts Payable1.490.230.460.090.990.471.531.120.43
Other Current Liabilities1.701.551.737.484.126.254.674.532.16
Total Current Liabilities3.912.082.477.585.397.766.815.952.63
Long Term Debt3.9710.730.100.001.983.842.880.560.02
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities17.583.14-------
Other Liabilities0.000.066.970.000.000.691.230.8216.23
Total Liabilities25.4616.019.547.587.3712.2910.937.3318.88
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7.0511.7621.199.2613.6721.1533.1566.70-7.62
Total Shareholders Equity7.0511.7621.199.2613.6721.1533.1566.70-7.62
Accumulated Minority Interest-0.400.000.000.000.000.000.000.000.00
Total Equity6.6511.7621.199.2613.6721.1533.1566.70-7.62
Total Liabilities & Stockholders Equity32.1127.7730.7416.8421.0433.4444.0874.0311.27
Book Value Per Share40.56279.075,730.598,141.60185,297.43629,967.085,717,447.7312,484,927.22-1,425,271.28
Tangible Book Value Per Share-47.05-297.11-1,385.808,141.60185,297.44629,967.095,717,449.3412,484,933.11-1,425,271.95
Full-Time Employees1722141458857911853
Price to Book Ratio0.010.310.130.670.801.120.471.5114.86
Return on Assets-57.39-56.89-296.70-141.84-100.07-91.13-96.44-72.29-207.64
Return on Equity-182.69-101.02-463.48-234.29-156.58-130.10-114.08-104.36-
Return on Invested Capital-155.85-74.02-331.48-290.12-182.34-144.24-158.06-45.84-
Quick Ratio0.081.561.672.222.993.454.8811.283.36
Current Ratio0.101.581.682.223.173.565.2811.643.81

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-13.19-17.70-16.64-70.57-26.86-25.07-36.05-56.96-30.83
Depreciation2.192.122.112.080.421.562.371.750.62
Other Funds (Non Cash)1.797.465.4354.940.49-3.764.3623.9514.98
Funds from Operations-9.82-9.93-9.10-13.55-25.95-27.27-29.32-31.26-15.22
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.501.62-0.20-7.070.55-0.361.01-1.92-3.28
Cash from Operating Activities-9.33-8.31-9.30-20.62-25.41-27.62-28.30-33.17-18.51
Capital Expenditures-0.23-0.13-0.07-0.08-0.02-0.27-0.07-0.27-0.58
Net Assets From Acquisitions-1.210.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.010.044.290.000.000.00
Purchase or Sale of Investments-0.520.300.000.000.000.0016.00-15.760.00
Purchase of Investments-1.000.000.000.000.000.000.00-36.460.00
Sale Or Maturity of Investments0.480.300.000.000.000.0016.0020.700.00
Other Uses0.000.000.000.000.00-0.230.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.960.17-0.07-0.060.023.8015.93-16.03-0.58
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock9.504.927.158.7423.3615.2319.990.0475.25
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock9.504.927.158.7423.3615.2319.990.0475.25
Proceedsfrom Stock Options4.180.002.617.1817.6515.1519.120.0475.25
Issuance or Reduction of Debt, Net0.990.441.52-0.360.00-0.271.71-0.34-0.08
Change in Long Term Debt3.250.300.00-0.250.00-0.271.71-0.34-0.08
Issuance of Long Term Debt3.510.300.000.000.000.002.000.000.00
Reduction of Long Term Debt-0.250.000.00-0.250.00-0.27-0.29-0.34-0.08
Net Financing Active Other Cash Flow0.600.000.000.000.000.000.00-0.230.00
Other Financing Activities Uses-0.000.000.000.000.000.00-0.230.00
Cash from Financing Activities11.095.368.688.3923.3614.9621.69-0.5375.17
Net Change in Cash-0.20-2.79-0.69-12.290.81-8.869.32-49.7356.08
Free Cash Flow-9.35-8.33-9.37-20.70-25.42-27.89-28.37-33.44-19.09
Preferred Dividends (Cash Flow)-0.00--0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--1.810.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.840.440.092.061.710.45
Short Term Receivables0.120.260.150.120.120.09
Inventories0.090.060.090.030.050.07
Other Current Assets0.460.480.060.250.170.25
Total Current Assets2.511.250.392.472.050.85
Net Property, Plant & Equipment2.641.760.230.260.260.17
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets31.5632.0215.2422.7423.2523.76
Deferred Tax Assets--16.25---
Other Assets0.160.060.010.010.010.01
Total Assets36.8735.0932.1125.4725.5624.80
Short Term Debt Incl. Current Port. of LT Debt9.238.060.722.682.151.71
Accounts Payable1.451.081.491.080.800.65
Other Current Liabilities2.7710.601.701.561.681.74
Total Current Liabilities13.4519.743.915.334.644.09
Long Term Debt5.244.743.9712.1512.9010.38
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities1.041.4517.581.541.472.42
Other Liabilities0.000.000.000.000.000.00
Total Liabilities19.7325.9325.4619.0219.0116.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity17.569.577.056.786.797.92
Total Shareholders Equity17.569.577.056.786.797.92
Accumulated Minority Interest-0.42-0.41-0.40-0.33-0.240.00
Total Equity17.149.166.656.456.557.92
Total Liabilities & Stockholders Equity36.8735.0932.1125.4725.5624.80
Book Value Per Share48.6535.5440.5641.1868.39162.27
Tangible Book Value Per Share-38.79-83.38-47.05-96.90-165.84-324.85
Full-Time Employees--17---
Price to Book Ratio0.010.280.450.610.670.40
Return on Assets-41.66-49.49-57.39-65.24-72.95-68.20
Return on Equity-106.82-169.51-182.69-173.74-179.11-136.26
Return on Invested Capital-14.45-11.75-52.41-11.89-25.94-22.11
Quick Ratio0.180.060.080.460.430.19
Current Ratio0.190.060.100.460.440.21

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-3.31-1.69-5.85-2.34-5.46-4.04
Depreciation0.640.500.530.530.530.53
Other Funds (Non Cash)-0.19-0.483.22-0.753.611.37
Funds from Operations-3.18-1.84-2.32-2.48-2.27-2.87
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.30-0.910.790.31-0.020.54
Cash from Operating Activities-2.87-2.75-1.52-2.18-2.29-2.33
Capital Expenditures-0.01-0.11-0.08-0.03-0.01-0.01
Net Assets From Acquisitions0.00-1.210.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.820.000.300.000.000.00
Purchase of Investments-1.000.000.000.000.000.00
Sale Or Maturity of Investments0.180.000.300.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.83-1.320.22-0.03-0.01-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)--0.000.000.000.00
Change in Capital Stock3.194.130.012.172.740.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.194.130.012.172.740.00
Proceedsfrom Stock Options3.193.73-3.741.002.740.00
Issuance or Reduction of Debt, Net0.120.290.310.27-0.05-0.09
Change in Long Term Debt1.970.830.48-0.03-0.08-0.07
Issuance of Long Term Debt2.370.830.300.000.000.00
Reduction of Long Term Debt-0.400.000.18-0.03-0.08-0.07
Net Financing Active Other Cash Flow0.600.000.000.000.000.00
Other Financing Activities Uses-0.000.000.000.000.00
Cash from Financing Activities3.914.430.322.442.69-0.09
Net Change in Cash0.200.35-0.990.240.39-2.42
Free Cash Flow-2.89-2.76-1.52-2.18-2.29-2.34

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 420.00K 2025: 819.00K
Europe2024: 142.00K 2025: 164.00K
United States2024: 278.00K 2025: 655.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3016.75%0.1M0.5M592.90K
2026-10-1550.89%0.3M0.5M650.62K
2026-09-301.07%0.0M1.7M811.33K
2026-09-151.35%0.0M1.7M1.08M
2026-08-318.63%0.0M0.5M1.05M
2026-08-141.05%0.0M1.2M1.01M
2026-07-3116.52%0.0M0.1M885.93K
2026-07-1547.51%0.1M0.1M793.46K
2026-06-3014.72%0.0M0.2M305.59K
2026-06-152.08%0.0M0.2M13.82K
2026-05-292.34%0.0M0.2M111.36K
2026-05-150.92%0.0M0.2M110.27K
2026-04-301.90%0.0M0.2M115.83K
2026-04-154.10%0.0M0.2M115.65K
2026-03-311.89%0.0M0.2M110.96K
2026-03-1315.54%0.0M0.1M109.22K
2026-02-275.46%0.0M0.1M8.21K
2026-02-138.11%0.0M0.1M8.06K
2026-01-301.26%0.0M0.2M3.66K
2026-01-151.84%0.0M0.2M3.97K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-148-KCurrent report2026-10-14SEC
2026-10-138-KCurrent report2026-10-12SEC
2026-10-098-KCurrent report2026-10-09SEC
2026-10-058-KCurrent report2026-10-05SEC
2026-10-028-KCurrent report2026-09-30SEC
2026-09-258-KCurrent report2026-09-24SEC
2026-08-31DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-30SEC
2026-08-21424B3SEC
2026-08-21PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-18SEC
2026-08-21SCHEDULE 13GSEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-318-KCurrent report2026-07-27SEC
2026-07-298-K/A2026-03-09SEC
2026-07-20SCHEDULE 13GSEC
2026-07-158-KCurrent report2026-07-14SEC
2026-07-10EFFECTEffectiveness filing by commission orderSEC
2026-07-10424B3SEC
2026-07-06S-1/ASEC
2026-06-26SCHEDULE 13GSEC
2026-06-22S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-06-088-KCurrent report2026-06-07SEC
2026-05-188-KCurrent report2026-05-18SEC
2026-05-1810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-18NT 10-Q2026-03-31SEC
2026-05-14SCHEDULE 13G/ASEC
2026-04-3010-K/A2025-12-31SEC
2026-04-238-KCurrent report2026-04-17SEC
2026-04-158-KCurrent report2026-04-15SEC
2026-03-318-KCurrent report2026-03-31SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Virtu Financial LLC0.74%
UBS Group AG0.63%
GEODE CAPITAL MANAGEMENT, LLC0.44%
Tower Research Capital LLC0.35%
OSAIC HOLDINGS, INC.0.32%
Allworth Financial LP0.00%
Purpose Unlimited Inc.0.00%
FMR LLC0.00%
HARBOUR INVESTMENTS, INC.0.00%
BARCLAYS PLC0.00%

Funds

Fund% owned
-

OakChart. VJET. Cached 15 minutes. Terms

Some panels did not load: insider.